Related Experiment Video
Updated: Jun 7, 2026

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
Soon Hak Suh1, Ryu Okutani, Masato Nakasuji
1Department of Anesthesiology, Kansai Denryoku Hospital, 2-1-7, Fukushima, Fukushima-ku, Osaka 553-0003, Japan. so.suna@b2.kepco.co.jp
Abstract:
We report a case of anesthesia during surgery to enlarge the foramen magnum in a pediatric patient with an extremely rare form of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). Airway control was unexpectedly easy, and intraoperative anesthetic management with total intravenous anesthesia went smoothly. However, the disease is progressive, with no guarantee that future anesthetic management of this patient will remain easy. If repeated surgery is required, thorough testing should be conducted over time to assess both airway and systemic complications. Nevertheless, we found that safe anesthetic management of affected patients is possible with anesthetics currently used in a clinical setting.
Insights
Anesthesia for surgery in a pediatric patient with Maroteaux-Lamy syndrome was unexpectedly smooth. Safe anesthetic management is possible, but future procedures require careful monitoring due to the progressive nature of this rare disease.
Area of Science:
- Anesthesiology
- Genetics
- Pediatric Surgery
Background:
- Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) is a rare, progressive genetic disorder.
- Surgical intervention, such as foramen magnum decompression, may be necessary in affected pediatric patients.
- Anesthetic management in these patients presents unique challenges due to potential airway and systemic complications.
Observation:
- A case report details the anesthetic management of a pediatric patient undergoing foramen magnum enlargement for Maroteaux-Lamy syndrome.
- Unexpectedly easy airway control was achieved during the procedure.
- Total intravenous anesthesia facilitated a smooth intraoperative course.
Findings:
- Safe anesthetic management for pediatric patients with mucopolysaccharidosis type VI is achievable with current clinical anesthetics.
- Despite a smooth initial experience, the progressive nature of the disease necessitates caution for future anesthetic encounters.
- Ongoing assessment of airway and systemic status is crucial if repeated surgeries are anticipated.
Implications:
- This case highlights the feasibility of safe anesthesia in rare genetic disorders like Maroteaux-Lamy syndrome.
- It underscores the importance of individualized anesthetic planning and vigilant monitoring in pediatric patients with complex conditions.
- Further research into long-term anesthetic outcomes for patients with mucopolysaccharidosis is warranted.
Related Concept Videos
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Cardiomyopathy VII: Pre and Post Operative Nursing Management

